Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARISOPRODOL vs CC-4047: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARISOPRODOL vs CC-4047: Safety Overview

Metric CARISOPRODOL CC-4047
Total FAERS Reports 2,660 114
Deaths Reported 1,332 65
Death Rate 50.1% 57.0%
Hospitalizations 432 49
Average Patient Age 48.1 yrs 67.0 yrs
% Female Patients 63.6% N/A
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer ScieGen Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A